NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

NCT05005845 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

199

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous Neurofibroma
Neurofibromatosis 1

Interventions

DRUG: NFX-179 gel
DRUG: Vehicle gel

Sponsor

NFlection Therapeutics, Inc.